Economic appraisal of Ontario's universal influenza immunization program: A cost-utility analysis

PLoS Medicine

Volumn 7, Issue 4, 2010, Pages

  Sander, Beate ^a,b,c   Kwong, Jeffrey C ^a,d,e   Bauch, Chris T ^c,f   Maetzel, Andreas ^a,g   McGeer, Allison ^b   Raboud, Janet M ^a,b   Krahn, Murray ^a,b,c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF GUELPH   (Canada)

^g AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MORTALITY; PREVENTIVE HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; ECONOMICS; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANADA; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; MIDDLE AGED; ONTARIO; YOUNG ADULT;

EID: 77951757376     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000256     Document Type: Article

References (56)

1. (2003) Influenza. Fact Sheet: World Health Organization.
2. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V (2007) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. CD001269 p.
3. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, et al. (1994) The efficacy of influenza vaccination in elderly individuals. A randomized double- blind placebo-controlled trial. JAMA 272: 1661-1665.
4. Neuzil KM, Dupont WD, Wright PF, Edwards KM (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20: 733-740.
5. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, et al. (1991) Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 145: 445-448.
6. Clements DA, Langdon L, Bland C, Walter E (1995) Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 149: 1113-1117.
7. Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, et al. (2001) Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 49: 157-162.
8. (2008) Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 34: 1-46.
9. (1993) Canadian Consensus Conference on Influenza. Can Commun Dis Rep 19: 136-142, 145-137.
10. Squires SG, Pelletier L (2000) Publicly-funded influenza and pneumococcal immunization programs in Canada: a progress report. Can Commun Dis Rep 26: 141-148.
11. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, et al. (2008) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57: 1-60.
12. (2000) Ontario invests $38 million to ease emergency room pressures with universal vaccination program. Ministry of Health and Long-Term Care.
13. Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, et al. (2008) The effect of universal influenza immunization on mortality and health care use. PLoS Med 5: e211. doi:10.1371/journal.pmed.0050211.
14. Moran K, Maaten S, Guttmann A, Northrup D, Kwong JC (2009) Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. Vaccine.
15. Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, et al. (2006) Guillain- Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 166: 2217-2221.
16. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, et al. (2003) Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 7: iii-iv, xi-xiii, 1-170.
17. Reisinger K, Greene G, Aultman R, Sander B, Gyldmark M (2004) Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children. Clin Drug Investig 24: 395-407.
18. Kwong JC, Stukel TA, McGeer AJ, Manuel DG (2007) Appropriate measures of influenza immunization program effectiveness. Vaccine 25: 967-969.
19. (2008) Mortality rate per 1,000 population. Canadian socio-economic information management system (CANSIM) Statistics Canada et al.
20. Mittmann N, Trakas K, Risebrough N, Liu BA (1999) Utility scores for chronic conditions in a community-dwelling population. PharmacoEconomics 15: 369-376.
21. (2006) HTA guidelines for the economic evaluation of health technologies. Ottawa.
22. (2008) Consumer price index (CPI), Ontario, Health Care, 1979-2007. Canadian socio-economic information management system (CANSIM) Statistics Canada et al.
23. (2008) JPPC Rate Model results based on 2006/07 data. Ontario Joint Policy and Planning Committee.
24. Pink GH, Bolley HB (1994) Physicians in health care management: 4. Case mix groups and resource intensity weights: physicians and hospital funding. CMAJ 150: 1255-1261.
25. Pink GH, Bolley HB (1994) Physicians in health care management: 3. Case mix groups and resource intensity weights: an overview for physicians. CMAJ 150: 889-894.
26. OCCI (Ontario Case Costing Initiative) (2009) Costing analysis tool.
27. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V (2008) Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. CD004879 p.
28. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, et al. (2006) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3: CD004876.
29. Esposito S, Marchisio P, Bosis S, Lambertini L, Claut L, et al. (2006) Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 24: 629-635.
30. Hibbert CL, Piedra PA, McLaurin KK, Vesikari T, Mauskopf J, et al. (2007) Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 25: 8010-8020.
31. Li S, Leader S (2007) Economic burden and absenteeism from influenza-like illness in healthy households with children (5-17 years) in the US. Respiratory Medicine 101: 1244-1250.
32. Marchetti M, Kuhnel UM, Colombo GL, Esposito S, Principi N (2007) Cost- effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Human Vaccines 3: 14-22.
33. Navas E, Salleras L, Dominguez A, Ibanez D, Prat A, et al. (2007) Cost- effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 25: 3233-3239.
34. Schmier J, Li S, King JC, Jr., Nichol K, Mahadevia PJ, et al. (2008) Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Health Affairs 27: w96-w104.
35. Teufel IRJ, Basco WT, Jr., Simpson KN (2008) Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma. J Hosp Med 3: 134-141.
36. Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, et al. (2006) Cost-effectiveness of influenza vaccination of healthy children. Vaccine 24: 4934-4941.
37. Aballea S, Chancellor J, Martin M, Wutzler P, Carrat F, et al. (2007) The cost- effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value in Health 10: 98-116.
38. Aballea S, De Juanes JR, Barbieri M, Martin M, Chancellor J, et al. (2007) The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 25: 6900-6910.
39. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ (2006) Influenza vaccination. Health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med 31: 72-79.
40. Newall AT, Scuffham PA, Kelly H, Harsley S, MacIntyre CR (2008) The cost- effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine 26: 2142-2153.
41. Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, et al. (2006) The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age. Vaccine 24: 1035-1043.
42. Colombo GL, Ferro A, Vinci M, Zordan M, Serra G (2006) Cost-benefit analysis of influenza vaccination in a public healthcare unit. Ther Clin Risk Manag 2: 219-226.
43. Rothberg MB, Rose DN (2005) Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med 118: 68-77.
44. Samad AH, Usul MHBHJ, Zakaria D, Ismail R, Tasset-Tisseau A, et al. (2006) Workplace vaccination against influenza in Malaysia: does the employer benefit? J Occup Health 48: 1-10.
45. Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, et al. (2007) Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer 109: 2357-2364.
46. Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD (2006) Cost- effectiveness of universal influenza vaccination in a pregnant population. Obstet Gynecol 107: 1323-1329.
47. Burls A, Jordan R, Barton P, Olowokure B, Wake B, et al. (2006) Vaccinating healthcare workers against influenza to protect the vulnerable-Is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 24: 4212-4221.
48. Chan AL, Shie HJ, Lee YJ, Lin SJ, Chan ALF, et al. (2008) The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan. Pharm World Sci 30: 39-43.
49. Ryan J, Zoellner Y, Gradl B, Palache B, Medema J (2006) Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 24: 6812-6822.
50. Cai L, Uchiyama H, Yanagisawa S, Kamae I (2006) Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan. Kobe J Med Sci 52: 97-109.
51. Gilman BH, Bonito AJ, Eicheldinger C (2007) Impact of influenza immunization on medical expenditures among medicare elderly, 1999-2003. Am J Prev Med 32: 107-115.
52. Hoshi SL, Kondo M, Honda Y, Okubo I (2007) Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan. Vaccine 25: 6511-6521.
53. Wang ST, Lee LT, Chen LS, Chen THH (2005) Economic evaluation of vaccination against influenza in the elderly: an experience from a population- based influenza vaccination program in Taiwan. Vaccine 23: 1973-1980.
54. Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC (2000) Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence. Drugs Aging 17: 217-227.
55. Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, et al. (2002) Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence. Drugs 62: 1013-1024.
56. Kunji K (2004) The Ontario experience with universal vaccination. National Influenza Vaccine Summit. Atlanta.